CheckMyRecalls

Glenmark Pharmaceuticals Inc., USA recalls

19 recall notices naming Glenmark Pharmaceuticals Inc., USA since January 2025, in United States. The most recent was published 4 Nov 2026.

Latest recalls (19)

  1. Glenmark Pharmaceuticals Inc., USA recalls Abiraterone Acetate Tablets USP 500 mgFDALabeling: Not Elsewhere Classified
  2. Glenmark Pharmaceuticals Inc., USA recalls Azelaic Acid GelFDACGMP Deviations: Product quality complaints concerning abnormal texture or consistency (described as grainy, gritty, or sandy) were received.
  3. Glenmark Pharmaceuticals Inc., USA recalls Alyacen 7/7/7FDAFailed Impurities/Degradation Specifications: This recall is being initiated due to out-of-specification results total impurities.
  4. Glenmark Pharmaceuticals Inc., USA recalls Ondansetron Orally Disintegrating TabletsFDADefective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and…
  5. Glenmark Pharmaceuticals Inc., USA recalls Nebivolol TabletsFDACross Contamination with Other Products
  6. Glenmark Pharmaceuticals Inc., USA recalls Bisoprolol Fumarate and Hydrochlorothiazide TabletsFDACross Contamination with Other Products: Testing of reserve samples showed presence of traces of ezetimibe
  7. Glenmark Pharmaceuticals Inc., USA recalls VioreleFDAFailed Impurities/Degradation Specifications
  8. Glenmark Pharmaceuticals Inc., USA recalls Azelaic Acid GelFDACGMP Deviations: Market complaints received for gritty texture (grainy)
  9. Glenmark Pharmaceuticals Inc., USA recalls Carvedilol TabletsFDACGMP Deviations: Presence of a nitrosamine, N-Nitroso Carvedilol I Impurity above the current Acceptable Intake Level.
  10. Glenmark Pharmaceuticals Inc., USA recalls Carvedilol TabletsFDACGMP Deviations: Results for N-Nitroso Carvedilol Impurity-1 (NNCI) impurity observed to be above the FDA-recommended limit of NMT 4.0 ppm
  11. Glenmark Pharmaceuticals Inc., USA recalls Theophylline extended-release tablets 400mgFDAFailed Dissolution Specifications: Failure results (above) were reported for the Dissolution (by UV) test for commercial annual stability at the…
  12. Glenmark Pharmaceuticals Inc., USA recalls Ezetimibe and Simvastatin TabletsFDAFailed Impurities/Degradation Specifications: Out of Specification (OOS) for related substances test for Anhydro Simvastatin at the 06-month time…
  13. Glenmark Pharmaceuticals Inc., USA recalls Carvedilol Tablets USP 25 mg and 3 moreFDACGMP Deviations; presence 'N-Nitroso Carvedilol I' Impurity above the recommended acceptable intake limit
  14. Glenmark Pharmaceuticals Inc., USA recalls Theophylline (Anhydrous) Extended-Release TabletsFDAOOS results reported for the Dissolution (by UV) test.
  15. Glenmark Pharmaceuticals Inc., USA recalls Cetirizine Hydrochloride Tablets and 35 moreFDACGMP Deviations
  16. Glenmark Pharmaceuticals Inc., USA recalls chlorproMAZINE Hydrochloride TabletsFDACGMP deviations: presence of N-Nitroso-Desmethyl Chlorpromazine impurity above the recommended interim limit.
  17. Glenmark Pharmaceuticals Inc., USA recalls Atomoxetine CapsulesFDACGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
  18. Glenmark Pharmaceuticals Inc., USA recalls Carvedilol TabletsFDACGMP Deviations:N-Nitroso Carvedilol I impurity (NNCI-I) were found to be failing per current FDA recommended limit.
  19. Glenmark Pharmaceuticals Inc., USA recalls chlorproMAZINE Hydrochloride TabletsFDACGMP Deviations: N-Nitroso-Desmethyl Chlorpromazine impurity (NNDCI) were found to be failing per current FDA recommended limit.